PLUS THERAPEUTICS INC (PSTV) Stock Income Statement
NASDAQ:PSTV - Nasdaq - US72941H5090 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.21M | 5.82M | 4.91M | 220.00K | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 20.14M | 20.52M | 18.23M | 19.94M | 12.17M | |||
| Research and Development | 9.57M | 10.58M | 9.69M | 9.70M | 5.32M | |||
| Selling, General, and Administrative Expenses | 10.56M | 9.94M | 8.54M | 10.24M | 6.85M | |||
| Operating Income | -14.93M | -14.70M | -13.32M | -19.71M | -12.17M | |||
| Interest Income/Expense | -16.39M | -3.45M | 5.00K | -560.00K | -910.00K | |||
| Other Income/Expense | 4.20M | 5.17M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -320.00K | |||
| Income Before Taxes | -27.12M | -12.98M | -13.32M | -20.28M | -13.40M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -27.12M | -12.98M | -13.32M | -20.28M | -13.40M | |||
| EBITDA | -14.22M | -13.97M | -12.69M | -19.09M | -11.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.51 | -1.95 | -4.24 | -11.58 | -16.54 | |||
| Non GAAP EPS | -2.61 | -2.17 | -4.53 | -12.60 | -1.13 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -520.90% | -222.84% | -271.04% | -9218.18% | N/A | |||
| Operating Profit Margin | -286.82% | -252.32% | -271.14% | -8959.09% | N/A | |||
All data in USD